Re: Rough Transcript RVX 21_05_12_PBA_at_Noon...
in response to
by
posted on
May 13, 2021 10:51PM
Great job as always Imtesty!
I'm still scratching my head on these two comments by Don. The average MP or MLA in Canada is probably as clueless re Reverlogix and the apabetalone story as your average Canadian. So, why is that? Who sat on really getting the story out for all of these years and didn't listen when we tried to tell them what they were doing wrong, and now we're supposed to be phoning our MP and MLA? I almost find it laughable, even though we all want this company to succeed!
I have a contact who if she made the call, could get her connection to bring this to the immediate attention of the provincial Minister of Health and the Chief Medical Officer in her province. No doubt whatsoever on that end, but given our track record - and especially since last September and onward - why would I? Why would I make her look stupid, given our track record?
You'd think - given what's happening out there - that the Resverlogix team would have every provincial Chief Medical Officer phoning them on a weekly or monthly basis by now, or am I way off here?
Absolutely mind-boggling!
Don from yesterday:
So if we could catch them going into the hospital, we have enough drug right now that we could dose every patient that was hospitalized for the last year in Canada with Apabetalone and clear out the hospitals completely and open our economies. So anybody listening who has contacts with MPs or your MLAs or whatever you have in your particular province, please let them know that this is available. And we can administer it as a clinical trial in a Phase II or III setting to every patient going in to a COVID hospital.
Don: I’d like to tell them once more go rattle your politician’s chain a little bit. Those guys have their hands full and I wouldn’t want their jobs right now. But whether it’s Kenney or Legault or Ford any of them I wouldn’t want it. But keep reminding them. The more they hear it the better. The faster things will move.